EU Votes to Hasten Generic Pricing, Leaves New Drug Timelines Alone

The European Parliament voted overwhelmingly in favor of a draft law that would require member states to decide on the pricing and reimbursement of generic medicines within 60 days of an application. On Feb. 6, a plenary session of the EU Parliament voted 559-54 (with 72 abstentions) in favor of the draft law, which is designed to speed up the availability of generic drugs. The legislation would revise the transparency rules for pricing and reimbursement of medicines (Directive 89/105/EEC), which have not been updated since 1989.
International Pharmaceutical Regulatory Monitor